For the quarter ending 2026-03-31, COLL has $1,651,955K in assets. $1,339,533K in debts. $268,648K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 268,648 | 231,252 | 150,096 | 117,348 |
| Marketable securities | 153,105 | 155,427 | 135,767 | 104,805 |
| Accounts receivable, net | 228,762 | 211,328 | 233,949 | 213,023 |
| Inventory | 42,741 | 40,912 | 38,052 | 38,148 |
| Prepaid expenses and other current assets | 32,562 | 32,642 | 36,156 | 56,037 |
| Restricted cash | 19,850 | 19,850 | 19,850 | 19,850 |
| Total current assets | 745,668 | 691,411 | 613,870 | 549,211 |
| Property and equipment, net | 11,661 | 12,013 | 12,249 | 12,903 |
| Operating lease assets | 3,975 | 4,187 | 4,432 | 5,263 |
| Intangible assets, net | 614,037 | 669,510 | 724,983 | 780,456 |
| Restricted cash | 1,058 | 1,056 | 1,054 | 1,050 |
| Deferred tax assets | 113,567 | 112,539 | 102,477 | 91,967 |
| Other noncurrent assets | 16,064 | 20,193 | 2,338 | 3,845 |
| Goodwill | 145,925 | 145,925 | 145,925 | 147,936 |
| Total assets | 1,651,955 | 1,656,834 | 1,607,328 | 1,592,631 |
| Accounts payable | 6,828 | 10,659 | 7,647 | 10,890 |
| Business combination consideration payable | - | - | 17,565 | 17,566 |
| Accrued liabilities | 58,148 | 62,464 | 51,468 | 59,436 |
| Accrued rebates, returns and discounts | 317,691 | 318,266 | 309,608 | 310,758 |
| Current portion of term notes payable | 32,625 | 29,000 | 64,583 | 64,583 |
| Current portion of operating lease liabilities | 1,449 | 1,407 | 1,372 | 1,338 |
| Business combination consideration payable | 17,565 | 17,565 | 19 | 38 |
| Deferred revenue | 667 | 667 | 667 | - |
| Total current liabilities | 434,973 | 440,028 | 452,929 | 464,609 |
| Term notes payable, net of current portion | 531,723 | 542,112 | 505,583 | 520,648 |
| Convertible senior notes | 238,472 | 238,213 | 237,950 | 237,688 |
| Operating lease liabilities, net of current portion | 3,787 | 4,132 | 4,501 | 4,853 |
| Deferred royalty obligation | 121,634 | 121,563 | 122,279 | 122,627 |
| Deferred revenue, net of current portion | 8,944 | 9,111 | 9,278 | 10,000 |
| Contingent consideration | - | 0 | - | - |
| Total liabilities | 1,339,533 | 1,355,159 | 1,332,520 | 1,360,425 |
| Common stock, 0.001 par value authorized shares - 100,000,000 40,629,601 issued and 31,600,879 outstanding shares as of march 31, 2026 and 39,646,749 issued and 31,440,155 outstanding shares as of december 31, 2024 | 41 | 41 | 41 | 40 |
| Additional paid-in capital | 621,743 | 624,954 | 615,077 | 598,938 |
| Treasury stock, at cost 9,028,722 shares as of march31, 2026 and december31, 2025 | 222,510 | 222,510 | 222,510 | 217,510 |
| Accumulated other comprehensive (loss) income | -219 | 319 | 292 | 337 |
| Accumulated deficit | -86,633 | -101,129 | -118,092 | -149,599 |
| Total shareholders equity | 312,422 | 301,675 | 274,808 | 232,206 |
| Total liabilities and shareholders equity | 1,651,955 | 1,656,834 | 1,607,328 | 1,592,631 |
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)